Are you Dr. Cosgrove?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 99 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1800 Orleans Street
Baltimore, MD 21287
Summary
- Dr. Sara Cosgrove, MD is an infectious disease specialist in Baltimore, Maryland. She is currently licensed to practice medicine in Maryland and Massachusetts. She is affiliated with Johns Hopkins Hospital and is an Associate Professor of Medicine at Director.
Education & Training
- Beth Israel Deaconess Medical CenterFellowship, Infectious Disease, 1998 - 2001
- Johns Hopkins UniversityResidency, Internal Medicine, 1995 - 1998
- Baylor College of MedicineClass of 1995
Certifications & Licensure
- MD State Medical License 2001 - 2026
- MA State Medical License 1998 - 2003
- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- 1430 citationsComparison of mortality associated with methicillin-resistant and methicillin-susceptible staphylococcus aureus bacteremia: A meta-analysisSara E. Cosgrove, George Sakoulas, Eli N. Perencevich, Mitchell J. Schwaber, Adolf W. Karchmer
Clinical Infectious Diseases. 2003-01-01 - 232 citationsCarbapenem Therapy Is Associated With Improved Survival Compared With Piperacillin-Tazobactam for Patients With Extended-Spectrum β-Lactamase BacteremiaPranita D. Tamma, Jennifer H. Han, Clare Rock, Anthony D. Harris, Ebbing Lautenbach
Clinical Infectious Diseases. 2015-05-01 - 51 citationsCefepime therapy for cefepime- susceptible extended-spectrum β-lactamase-producing enterobacteriaceae bacteremiaRuibin Wang, Sara E. Cosgrove, Sarah Tschudin-Sutter, Jennifer H Han, Alison E. Turnbull
Open Forum Infectious Diseases. 2016-05-01
Press Mentions
- Johns Hopkins Medicine Awarded $10 Million to Optimize Antibiotic Therapy for Bacterial InfectionsNovember 21st, 2022
- Tighter Controls on Antibiotics Promise to Curb Drug-ResistanceNovember 21st, 2022
- Maximizing Benefits and Minimizing Harms from Antibiotics: Scientific, Regulatory and Clinical Considerations by Dr. Sara Cosgrove November 8, 2022November 8th, 2022
- Join now to see all